Imaging compounds for detecting or imaging senescent cells
AssigneeUniversity of Dundee
InventorsVassilis G. Gorgoulis, Nikolaos Lougiakis, Panagiotis Marakos, Nicole Pouli, Anthanassios Kotsinas, Konstantinos Evangelou, Russell Petty, Ilias Christos Tzortzatos
Life of this patent
Estimating the term…
Abstract
A compound, or a salt or solvate thereof, according to formula I as defined herein and pharmaceutical composition comprising said compound. Compounds of formula I are capable of detecting senescence. As such, these compounds are useful in methods of detecting or imaging senescent cells or extracts thereof or senescence in a subject or a biological sample taken from a subject.
Claims24
A compound, or a salt or solvate thereof, according to formula I:
- T-L-D (I)
- wherein
- D is a fluorescent dye moiety selected from:
- (i) a cyanine dye moiety;
- (ii) a BODIPY dye moiety;
- (iii) a coumarin dye moiety;
- and
- (iv) a xanthene dye moiety, with the proviso that the xanthene dye moiety is not fluorescein;
- L is a direct bond or a linking moiety;
- and
- T is a lipid-targeting moiety of formula II or III:
- wherein
- R1 and R2b are each independently selected from hydrogen;
- an optionally substituted (C1-10)alkyl group;
- an optionally substituted aryl group;
- and an optionally substituted aryl(C1-10)alkyl group;
- or
- R1 and R2b, together with the carbon to which they are attached, form an optionally substituted C4 to C12 carbocyclic ring;
- R2a is selected from an optionally substituted (C1-10)alkylene group;
- an optionally substituted arylene group;
- an optionally substituted aryl(C1-10)alkylene group;
- or
- R1 and R2a together with the carbon to which they are attached form an optionally substituted C4 to C12 carbocyclic ring;
- each R3 is independently hydrogen or a (C1-10)alkyl group;
- R4a is selected from hydrogen, halogen, optionally substituted C1-10 alkyl, optionally substituted C1-10 haloalkyl, optionally substituted C1-10 haloalkoxy, —ORA4, —SRA4, —NRA4RB4, —CN, —NO2, —N3, —NRA4C(O)RB4, —C(O)NRA4RB4, —NRA4C(O)ORB4, —OC(O)NRA4RB4, —NRA4C(O)NRA4RB4, —NRA4SO2RB4, —SO2NRA4RB4, —SO2RA4, —NRA4C(S)RB4, —C(S)NRA4RB4, —C(O)RA4, —C(O)ORA4, optionally substituted C3-6 cycloalkyl and an optionally substituted 3-7 membered heterocycloalkyl group;
- q is an integer of value 0, 1, 2 or 3;
- R4b is selected from a direct bond, —O—, —S—, —NRC4—, —NRC4C(═O)—, —C(═O)NRC4—, an optionally substituted (C1-10)alkylene group;
- and an optionally substituted (C1-10)heteroalkylene group;
- and
- RA4, RB4 and RC4, at each occurrence, are independently selected hydrogen, C1-6 alkyl and C1-6 heteroalkyl.
A compound, or salt or solvate thereof, selected from:
(canceled)
22-25. (canceled)
27-29. (canceled)
Dependencies are inferred from the claim text.